Advances in the Multimodality Imaging and Management of Recurrent Pericarditis: A Contemporary Review

Overview

Journal Curr Cardiol Rep

Publisher Current Science

Specialty Cardiology & Vascular Diseases

Date 2024 Sep 20

PMID 39302591

Authors

Harsha Sanaka

Elio Haroun

Aro Daniela Arockiam

Tiffany Dong

Allan Klein

Tom Kai Ming Wang

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: To outline recent advances in imaging and treatment for recurrent pericarditis (RP).

Recent Findings: Greater understanding of NLRP3 inflammasome activation in the pathogenesis of RP has led to the development of several anti-interleukin (IL-1) agents, and technological advancements have increased the utility of multimodality imaging in RP. Multimodality imaging plays a crucial role in the assessment of RP, with echocardiography serving as the initial imaging modality; cardiac magnetic resonance (CMR) as a pivotal test for diagnosis, grading severity, and surveillance; and cardiac computed tomography (CT) providing complimentary information and assisting operative assessment. Anti-IL-1 agents are now well-established as second line therapy for RP, with recent clinical trials demonstrating their efficacy.

References

Launbjerg J, Fruergaard P, Hesse B, Jorgensen F, Elsborg L, Petri A . Long-term risk of death, cardiac events and recurrent chest pain in patients with acute chest pain of different origin. Cardiology. 1996; 87(1):60-6. DOI: 10.1159/000177061. View

Klein A, Cremer P, Kontzias A, Furqan M, Tubman R, Roy M . US Database Study of Clinical Burden and Unmet Need in Recurrent Pericarditis. J Am Heart Assoc. 2021; 10(15):e018950. PMC: 8475691. DOI: 10.1161/JAHA.120.018950. View

Adler Y, Charron P, Imazio M, Badano L, Baron-Esquivias G, Bogaert J . 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for.... Eur Heart J. 2015; 36(42):2921-2964. PMC: 7539677. DOI: 10.1093/eurheartj/ehv318. View

Imazio M, CECCHI E, Demichelis B, Chinaglia A, Ierna S, Demarie D . Myopericarditis versus viral or idiopathic acute pericarditis. Heart. 2007; 94(4):498-501. DOI: 10.1136/hrt.2006.104067. View

Yesilyaprak A, Kumar A, Agrawal A, Verma B, Berglund F, Imazio M . Prognostic Value of Etiology in Patients With Recurrent Pericarditis. J Am Coll Cardiol. 2023; 81(20):2056-2058. DOI: 10.1016/j.jacc.2023.03.406. View

Muruve D, Petrilli V, Zaiss A, White L, Clark S, Ross P . The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature. 2008; 452(7183):103-7. DOI: 10.1038/nature06664. View

Park H, Bourla A, Kastner D, Colbert R, Siegel R . Lighting the fires within: the cell biology of autoinflammatory diseases. Nat Rev Immunol. 2012; 12(8):570-80. PMC: 4165575. DOI: 10.1038/nri3261. View

Bonaventura A, Vecchie A, Mauro A, Brucato A, Imazio M, Abbate A . An update on the pathophysiology of acute and recurrent pericarditis. Panminerva Med. 2020; 63(3):249-260. DOI: 10.23736/S0031-0808.20.04205-6. View

Fahey E, Doyle S . IL-1 Family Cytokine Regulation of Vascular Permeability and Angiogenesis. Front Immunol. 2019; 10:1426. PMC: 6603210. DOI: 10.3389/fimmu.2019.01426. View

10.

Ozen S, Demirkaya E, Amaryan G, Kone-Paut I, Polat A, Woo P . Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children. Ann Rheum Dis. 2013; 73(4):662-7. DOI: 10.1136/annrheumdis-2012-202708. View

11.

Cantarini L, Vitale A, Lucherini O, De Clemente C, Caso F, Costa L . The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy. Clin Rheumatol. 2014; 34(1):17-28. DOI: 10.1007/s10067-014-2721-0. View

12.

Brucato A, Imazio M, Gattorno M, Lazaros G, Maestroni S, Carraro M . Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial. JAMA. 2016; 316(18):1906-1912. DOI: 10.1001/jama.2016.15826. View

13.

Brucato A, Emmi G, Cantarini L, Lenarda A, Gattorno M, Lopalco G . Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism. Intern Emerg Med. 2018; 13(4):475-489. DOI: 10.1007/s11739-018-1842-x. View

14.

Peet C, Rowczenio D, Omoyinmi E, Papadopoulou C, Mapalo B, Wood M . Pericarditis and Autoinflammation: A Clinical and Genetic Analysis of Patients With Idiopathic Recurrent Pericarditis and Monogenic Autoinflammatory Diseases at a National Referral Center. J Am Heart Assoc. 2022; 11(11):e024931. PMC: 9238712. DOI: 10.1161/JAHA.121.024931. View

15.

Klein A, Imazio M, Cremer P, Brucato A, Abbate A, Fang F . Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis. N Engl J Med. 2020; 384(1):31-41. DOI: 10.1056/NEJMoa2027892. View

16.

Cantarini L, Lopalco G, Selmi C, Napodano S, De Rosa G, Caso F . Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis. Autoimmun Rev. 2014; 14(2):90-7. DOI: 10.1016/j.autrev.2014.10.005. View

17.

van Kempen T, Wenink M, Leijten E, Radstake T, Boes M . Perception of self: distinguishing autoimmunity from autoinflammation. Nat Rev Rheumatol. 2015; 11(8):483-92. DOI: 10.1038/nrrheum.2015.60. View

18.

Caforio A, Brucato A, Doria A, Brambilla G, Angelini A, Ghirardello A . Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart. 2010; 96(10):779-84. DOI: 10.1136/hrt.2009.187138. View

19.

Brucato A, Brambilla G, Moreo A, Alberti A, Munforti C, Ghirardello A . Long-term outcomes in difficult-to-treat patients with recurrent pericarditis. Am J Cardiol. 2006; 98(2):267-71. DOI: 10.1016/j.amjcard.2006.01.086. View

20.

Kumar S, Khubber S, Reyaldeen R, Agrawal A, Cremer P, Imazio M . Advances in Imaging and Targeted Therapies for Recurrent Pericarditis: A Review. JAMA Cardiol. 2022; 7(9):975-985. DOI: 10.1001/jamacardio.2022.2584. View